Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Coombes

Showing results (271-280 of 334) with videos related to

Pageof 34
Sort By:
Bioinformatics (Oxford, England)|November 9, 2014
Development of a robust classifier for quality control of reverse-phase protein arraysZhenlin Ju, Wenbin Liu, Paul L Roebuck, et al.
Annals of Hematology|August 16, 2012
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsTwee Tsao, Yuexi Shi, Steven Kornblau, et al.
Blood|February 15, 2003
High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemiaHelen McCarthy, William G Wierda, Lynn L Barron, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Blood|November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AMLBing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Proteomics|March 6, 2018
Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia PatientsAnneke D van Dijk, Chenyue W Hu, Eveline S J M de Bont, et al.
Breast Cancer Research and Treatment|February 5, 2005
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometryTimothy M Pawlik, Herbert Fritsche, Kevin R Coombes, et al.
Cancer Discovery|January 30, 2023
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV IntegrationKeiko Akagi, David E Symer, Medhat Mahmoud, et al.
Blood|May 31, 2012
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AMLBing Z Carter, Yihua Qiu, Xuelin Huang, et al.
Plos One|December 24, 2011
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemiaCarmen D Schweighofer, Kevin R Coombes, Lynn L Barron, et al.
Pageof 34

Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
Bioinformatics (Oxford, England)|November 9, 2014
Development of a robust classifier for quality control of reverse-phase protein arraysZhenlin Ju, Wenbin Liu, Paul L Roebuck, et al.
Annals of Hematology|August 16, 2012
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsTwee Tsao, Yuexi Shi, Steven Kornblau, et al.
Blood|February 15, 2003
High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemiaHelen McCarthy, William G Wierda, Lynn L Barron, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Blood|November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AMLBing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Proteomics|March 6, 2018
Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia PatientsAnneke D van Dijk, Chenyue W Hu, Eveline S J M de Bont, et al.
Breast Cancer Research and Treatment|February 5, 2005
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometryTimothy M Pawlik, Herbert Fritsche, Kevin R Coombes, et al.
Cancer Discovery|January 30, 2023
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV IntegrationKeiko Akagi, David E Symer, Medhat Mahmoud, et al.
Blood|May 31, 2012
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AMLBing Z Carter, Yihua Qiu, Xuelin Huang, et al.
Plos One|December 24, 2011
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemiaCarmen D Schweighofer, Kevin R Coombes, Lynn L Barron, et al.
Pageof 34